Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Name_of_Study,Research_Information_Link,Context_of_Research
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,122.60,11/11/2013,"In-kind items and services",24486800,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,122.60,11/11/2013,"In-kind items and services",24486799,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,122.60,11/11/2013,"In-kind items and services",24486831,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,89.30,11/11/2013,"In-kind items and services",24486512,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,89.30,11/11/2013,"In-kind items and services",24486303,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,75.84,11/11/2013,"In-kind items and services",24486511,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,61.30,11/11/2013,"In-kind items and services",24486833,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
765266,"Merck Sharp & Dohme Corporation",NJ,100000000053,49.04,11/11/2013,"In-kind items and services",24486832,MK-3475,"","A Phase IIIII Randomized Trial of Two Doses of MK-3475 SCH 900475 versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer","",""
